Separately, Zacks Investment Research upgraded Safeguard Scientifics from a “hold” rating to a “buy” rating and set a $10.00 price target for the company in a research report on Tuesday, March 3rd.
Shares of SFE stock traded up $0.15 during trading hours on Monday, reaching $6.48. The company had a trading volume of 119,926 shares, compared to its average volume of 84,846. The company has a debt-to-equity ratio of 0.03, a quick ratio of 6.78 and a current ratio of 6.78. The stock has a fifty day moving average of $6.15 and a 200-day moving average of $8.79. The company has a market capitalization of $131.05 million, a price-to-earnings ratio of 7.81 and a beta of 1.40. Safeguard Scientifics has a 12-month low of $4.43 and a 12-month high of $12.91.
In other Safeguard Scientifics news, Director Joseph M. Jr. Manko acquired 10,000 shares of the stock in a transaction that occurred on Wednesday, May 6th. The stock was bought at an average cost of $6.26 per share, for a total transaction of $62,600.00. Following the completion of the transaction, the director now owns 9,612 shares of the company’s stock, valued at approximately $60,171.12. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, Director Joseph M. Jr. Manko acquired 16,229 shares of the stock in a transaction that occurred on Friday, May 22nd. The stock was acquired at an average price of $6.80 per share, with a total value of $110,357.20. Following the completion of the transaction, the director now directly owns 9,612 shares of the company’s stock, valued at approximately $65,361.60. The disclosure for this purchase can be found here. Insiders purchased 71,026 shares of company stock valued at $470,221 over the last quarter. 6.40% of the stock is currently owned by company insiders.
Institutional investors and hedge funds have recently added to or reduced their stakes in the company. BNP Paribas Arbitrage SA boosted its position in shares of Safeguard Scientifics by 114.8% during the first quarter. BNP Paribas Arbitrage SA now owns 6,061 shares of the asset manager’s stock worth $34,000 after buying an additional 3,239 shares during the period. Great West Life Assurance Co. Can purchased a new position in shares of Safeguard Scientifics during the fourth quarter worth $70,000. Requisite Capital Management LLC purchased a new position in shares of Safeguard Scientifics during the first quarter worth $72,000. Engineers Gate Manager LP purchased a new position in shares of Safeguard Scientifics during the first quarter worth $93,000. Finally, Los Angeles Capital Management & Equity Research Inc. purchased a new position in shares of Safeguard Scientifics during the first quarter worth $192,000. Institutional investors and hedge funds own 70.72% of the company’s stock.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc no longer investing. It is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. It initially invests in a Series A-C round and opportunistically in a seed round.
Featured Article: The Role of a Fiduciary and Individual Investors
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Safeguard Scientifics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics and related companies with MarketBeat.com's FREE daily email newsletter.